EUVIMEDEUVIMED entdecken
Metaanalyse

1756-P: Efficacy and Safety of Inhaled vs. Subcutaneous Insulin: A Meta-Analysis

ALI RAZA KHAN, ABDUL RAFEH AWAN, HIRA SALEEM, ABDULLAH AHMAD, MUHAMMAD DANIYAL, WANIA SULTAN, SYED HASHAM ALI

Diabetes · 05.06.2026 · 75 (Supplement_1)

DOI: 10.2337/db26-1756-p ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Diabetes, erschienen am 05.06.2026. Verfasst von ALI RAZA KHAN und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and Objective: Inhaled insulin offers a non-invasive, patient-friendly alternative to SQ insulin. This meta-analysis was carried out to determine the efficacy, side effects, and clinical applicability of inhaled insulin in both Type 1 and Type 2 DM.

Methods

RCTs were obtained from PubMed, Cochrane, Embase, and WOS databases comparing inhaled insulin with SQ insulin in Type 1 and/or Type 2 DM patients. Trials involving animals, crossover designs, comparisons of inhaled insulin with oral anti-diabetic drugs, and those lasting less than 12 weeks were excluded. Data on HbA1c, fasting blood glucose, body weight, and pulmonary function were analyzed using RevMan 5.4 with p < 0.05 considered statistically significant and a 95% confidence interval [95% CI].

Results

Analysis of 19 RCTs revealed that patients using inhaled insulin experienced a significant reduction in fasting blood glucose (Mean difference (MD): -22.12 [-29.29, -14.95]) and non-significant number of patients achieving HbA1c <7%. Inhaled insulin was associated with significant weight reduction but a significant decrease in DLCO (MD: -0.44 [-0.78, -0.11]) and FEV1 (MD: -0.03 [-0.04, -0.01]).

Conclusion

Inhaled insulin offers a promising alternative to SQ insulin, with comparable glycemic control, improved fasting glucose and weight management. However, further studies are needed to assess its impact on pulmonary function and enhance its safety profile. Disclosure A. Khan: None. A. Awan: None. H. Saleem: None. A. Ahmad: None. M. Daniyal: None. W. Sultan: None. S. Ali: None.

Zitieren

APA

KHAN, A. R., AWAN, A. R., SALEEM, H., AHMAD, A., DANIYAL, M., SULTAN, W., & ALI, S. H. (2026). 1756-P: Efficacy and Safety of Inhaled vs. Subcutaneous Insulin: A Meta-Analysis. Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-1756-p

Vancouver

KHAN AR, AWAN AR, SALEEM H, AHMAD A, DANIYAL M, SULTAN W, et al. 1756-P: Efficacy and Safety of Inhaled vs. Subcutaneous Insulin: A Meta-Analysis. Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-1756-p

BibTeX
@article{KHAN2026,
  author = {KHAN, ALI RAZA and AWAN, ABDUL RAFEH and SALEEM, HIRA and AHMAD, ABDULLAH and DANIYAL, MUHAMMAD and SULTAN, WANIA and ALI, SYED HASHAM},
  title = {1756-P: Efficacy and Safety of Inhaled vs. Subcutaneous Insulin: A Meta-Analysis},
  journal = {Diabetes},
  year = {2026},
  volume = {75},
  number = {Supplement_1},
  doi = {10.2337/db26-1756-p}
}
Kostenlos starten →